NASDAQ:LFWD - Nasdaq - IL0011331076 - Common Stock - Currency: USD
LIFEWARD LTD
NASDAQ:LFWD (2/10/2025, 8:10:14 PM)
Premarket: 2.05 +0.18 (+9.63%)1.87
+0.47 (+33.57%)
The current stock price of LFWD is 1.87 USD. In the past month the price decreased by -1.32%. In the past year, price increased by 104.6%.
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
MARLBOROUGH, Mass., and YOKNEAM ILLIT, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.12 | 227.75B | ||
ISRG | INTUITIVE SURGICAL INC | 81.27 | 212.18B | ||
BSX | BOSTON SCIENTIFIC CORP | 42.3 | 156.49B | ||
SYK | STRYKER CORP | 32.21 | 149.67B | ||
MDT | MEDTRONIC PLC | 17.3 | 116.48B | ||
BDX | BECTON DICKINSON AND CO | 17.44 | 66.57B | ||
EW | EDWARDS LIFESCIENCES CORP | 26.63 | 41.93B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.73 | 39.98B | ||
IDXX | IDEXX LABORATORIES INC | 41.33 | 38.07B | ||
RMD | RESMED INC | 26.99 | 35.02B | ||
DXCM | DEXCOM INC | 51.92 | 34.48B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 20.74 | 25.93B |
ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The firm offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
LIFEWARD LTD
3 Hatnufa st. 6th fl., P.O. Box 161
Yokneam IL
Employees: 108
Company Website: https://golifeward.com/
Investor Relations: http://ir.rewalk.com/phoenix.zhtml?c=253715&p=irol-irhome
Phone: 97249590123
The current stock price of LFWD is 1.87 USD.
The exchange symbol of LIFEWARD LTD is LFWD and it is listed on the Nasdaq exchange.
LFWD stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for LFWD, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of LFWD.
LFWD does not pay a dividend.
LFWD will report earnings on 2025-02-20, after the market close.
LFWD does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.49).
The outstanding short interest for LFWD is 3.14% of its float.
ChartMill assigns a technical rating of 2 / 10 to LFWD. When comparing the yearly performance of all stocks, LFWD is one of the better performing stocks in the market, outperforming 93.74% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to LFWD. While LFWD seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months LFWD reported a non-GAAP Earnings per Share(EPS) of -2.49. The EPS decreased by 3.86% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -42.17% | ||
ROE | -56.95% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to LFWD. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 33.9% and a revenue growth 78.92% for LFWD